For nearly one-third of the 3 million adults in the United States living with epilepsy, medications fail to control seizures.

110 patients with severe refractory epilepsy, who previously had not perceived any beneficial effects from at least three different AEDs, fulfilled the study inclusion and exclusion criteria.

Argent BioPharma’s flagship cannabinoid-based therapy for refractory epilepsy has been approved for prescription in Germany. ...

Common Anti-Epileptic Drugs. There are several anticonvulsant drugs that are commonly prescribed. Understanding how your medications work, and their possible side effects, is an i ...

Rapport Therapeutics focuses on developing specific small molecule therapies for CNS diseases. Check out my recommendation ...

CannEpil, a cannabinoid-based therapy for refractory epilepsy, has been approved for prescription in Germany under a special ...

A real-world study supports cenobamate as an effective option for patients with drug-resistant epilepsy even after multiple ...

We evaluated our clinical experience with zonisamide, a broad-spectrum antiepileptic drug, in a group of children with predominantly medically refractory epilepsy. A retrospective chart review was ...

Developmental and epileptic encephalopathy 81 (DEE81) presents a complex challenge in diagnosis and management due to its rarity and diverse clinical manifestations. Here, we report the case of a ...